TNF and chronic obstructive pulmonary disease: We previously reported that TNF-α-induced GM-CSF production in PBECs from GOLD stage II COPD patients was less responsive to the clinically used inhaled glucocorticoid budesonide compared with nonsmoking controls, with an intermediate effect of budesonide in PBECs from control smokers (16).